PineBridge Investments, L.P. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 253 filers reported holding REPLIGEN CORP in Q1 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
PineBridge Investments, L.P. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2021$79,000
-97.0%
300
-99.1%
0.00%
-97.7%
Q3 2019$2,658,000
-3.6%
34,662
+8.0%
0.04%
-4.4%
Q2 2019$2,758,000
+370.6%
32,090
+223.5%
0.04%
+275.0%
Q1 2019$586,000
+11.6%
9,920
-0.4%
0.01%0.0%
Q4 2018$525,000
+10.5%
9,959
+16.3%
0.01%
+33.3%
Q3 2018$475,000
+38.9%
8,562
+18.0%
0.01%
+12.5%
Q2 2018$342,000
+21.3%
7,259
-6.8%
0.01%
+14.3%
Q1 2018$282,000
-55.7%
7,792
-55.7%
0.01%
-56.2%
Q4 2017$637,000
+257.9%
17,573
+279.1%
0.02%
+300.0%
Q3 2017$178,000
-4.3%
4,636
+3.2%
0.00%
-20.0%
Q2 2017$186,000
+19.2%
4,491
+1.7%
0.01%
+25.0%
Q1 2017$156,000
+18.2%
4,415
+2.8%
0.00%0.0%
Q4 2016$132,000
+1.5%
4,2960.0%0.00%
-33.3%
Q3 2016$130,000
+11.1%
4,296
+0.7%
0.01%0.0%
Q2 2016$117,000
+8.3%
4,266
+5.7%
0.01%0.0%
Q1 2016$108,000
-13.6%
4,036
-8.7%
0.01%
+20.0%
Q4 2015$125,000
+14.7%
4,421
+13.0%
0.01%0.0%
Q3 2015$109,000
-25.9%
3,911
+10.3%
0.01%
-16.7%
Q2 2015$147,000
-37.4%
3,545
-54.1%
0.01%
-33.3%
Q1 2015$235,000
+69.1%
7,724
+10.1%
0.01%
+80.0%
Q4 2014$139,000
+3.7%
7,015
+4.7%
0.01%0.0%
Q3 2014$134,000
+28.8%
6,697
+46.0%
0.01%
+25.0%
Q2 2014$104,0004,5860.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Miura Global Management 275,000$15,252,0002.81%
Conestoga Capital Advisors, LLC 1,941,212$107,660,0002.75%
Ranger Investment Management 627,311$34,791,0002.30%
Tygh Capital Management, Inc. 130,041$7,212,0001.18%
PALISADE CAPITAL MANAGEMENT, LP 763,457$42,341,0001.17%
AWM Investment Company, Inc. 121,000$6,711,0001.11%
Pier Capital, LLC 150,342$8,338,0001.05%
Summit Creek Advisors LLC 113,417$6,290,0001.01%
Stephens Investment Management Group LLC 882,086$48,920,0000.90%
Lisanti Capital Growth, LLC 44,405$2,463,0000.86%
View complete list of REPLIGEN CORP shareholders